All posts by: MarksMan Healthcare

About MarksMan Healthcare

MarksMan Healthcare Communications

Systematic reviews (SRs) are incredibly crucial for healthcare decision-making, as they often provide a reliable summary of evidence on the comparison among healthcare interventions. They identify, assess, and combine the results of similar but individual studies and help to clarify the known and unknown benefits and risks associated with drugs, devices, and other healthcare interventions. […]

The need for transparency in drug pricing is getting severe with increased spending on medications with each passing year. Drug spending in the US, without the discounts, has been reported to be $309.5 billion in the year 2015, which is about 8.5% higher than that reported in the preceding year. (1) As a result, undoubtedly, […]

Health utilities are cardinal values in identifying an individual’s preference for different health outcomes. Health utilities are transformed to Quality Adjusted Life Years (QALYs) to enable comparisons between health interventions in cost-utility analysis in Pharmacoeconomics. Health utilities are measured using various utility ‘instruments’, which can be either generic (that is, can be applied to all […]

During the course of any research, most of the relevant literature pertaining to a research question is retrieved though searching of recognised databases. However, in addition to this, searching of grey literature can add value to the depth of the research by providing information from varied sources. Grey literature search is an important, but often […]

Healthcare management is a combination of information science, computer science, information technology and healthcare. It incorporates resources, devices, and methods for optimising the acquisition, storage, retrieval, and use of data in health and biomedicine. This includes not only computers, but also clinical guidelines, medical terminologies as well as information and communication systems. Research and development […]

The transformation of healthcare from volume-based to value-based mode has encouraged public and private payers to reform reimbursement models emphasizing on accountability for care quality and healthcare costs. Thanks to the ever-increasing healthcare costs, payers and providers are increasingly preferring bundled payments over fee-for-service (FFS) payment structures. (1,2) Bundled payments, also known as episode payments/case […]